These polymorphisms, which involve amino acid changes at evolutionarily conserved sequences, could alter the function of XRCC1, which may diminish repair kinetics in individuals with the variant alleles and increase the risk of glioma in humans. This evidence concerns the gene XRCC1 and glioma.